Skip to main content Help with accessibility Skip to main navigation

Position Statements

BwD
Adopted
BP
Adopted
CSR
Adopted
EL
Adopted
FW
Adopted
GP
Adopted
MB
Adopted
WL
Adopted

Biological agents for treating Juvenile Idiopathic Arthritis (JIA) in adult patients

Date Posted: 01 - June - 2015
BNF chapter: Immune system and Malignant Disease Musculoskeletal system
BwD
Adopted
BP
Adopted
CSR
Adopted
EL
Adopted
FW
Adopted
GP
Adopted
MB
Adopted
WL
Adopted

Denosumab

Date Posted: 01 - February - 2018
BNF chapter: Endocrine system Musculoskeletal system

Denosumab as a second-line treatment option for the prevention of Osteoporotic Fragility Fractures